• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The treatment of diabetic macular edema with intravitreal bevacizumab in users of the Brazilian public health system.巴西公共卫生系统使用者中玻璃体内注射贝伐单抗治疗糖尿病性黄斑水肿
Arq Bras Oftalmol. 2024 Sep 13;87(5):e20240146. doi: 10.5935/0004-2749.2024-0146. eCollection 2024.
2
Short-term efficacy of intravitreal triamcinolone acetonide for bevacizumab-resistant diabetic macular oedema.玻璃体内注射曲安奈德治疗抗贝伐单抗的糖尿病性黄斑水肿的短期疗效
Acta Ophthalmol. 2015 Mar;93(2):e178-9. doi: 10.1111/aos.12504. Epub 2014 Jul 10.
3
Intravitreal fasudil combined with bevacizumab for persistent diabetic macular edema: a novel treatment.
JAMA Ophthalmol. 2013 Jul;131(7):923-4. doi: 10.1001/jamaophthalmol.2013.143.
4
Effect of intravitreal bevacizumab based on optical coherence tomography patterns of diabetic macular edema.基于光学相干断层扫描模式的糖尿病性黄斑水肿眼内注射贝伐单抗的疗效。
Ophthalmologica. 2011;226(3):138-44. doi: 10.1159/000330045. Epub 2011 Aug 3.
5
[Avastin a treatment of diabetic macular edema].
Oftalmologia. 2011;55(1):63-7.
6
Comparison of a single intravitreal injection of bevacizumab versus triamcinolone acetonide as primary treatment for diffuse diabetic macular oedema.单次玻璃体内注射贝伐单抗与曲安奈德作为弥漫性糖尿病性黄斑水肿主要治疗方法的比较
Acta Ophthalmol. 2012 Mar;90(2):e160-1. doi: 10.1111/j.1755-3768.2010.02098.x. Epub 2011 Apr 6.
7
Intravitreal bevacizumab (Avastin) versus triamcinolone (Volon A) for treatment of diabetic macular edema: one-year results.玻璃体腔内注射贝伐单抗(阿瓦斯汀)与曲安奈德(伏伦达)治疗糖尿病性黄斑水肿:一年的结果。
Eye (Lond). 2014 Jan;28(1):9-15; quiz 16. doi: 10.1038/eye.2013.242. Epub 2013 Dec 13.
8
Intravitreal foreign body following intravitreal anti-VEGF injection: a case report.玻璃体内抗VEGF注射后发生玻璃体内异物:一例报告
Eye (Lond). 2014 Feb;28(2):244-5. doi: 10.1038/eye.2013.250. Epub 2013 Dec 20.
9
Factors Influencing Intravitreal Bevacizumab and Triamcinolone Treatment in Patients with Diabetic Macular Edema.影响糖尿病性黄斑水肿患者玻璃体内注射贝伐单抗和曲安奈德治疗的因素
Eur J Ophthalmol. 2017 Nov 8;27(6):746-750. doi: 10.5301/ejo.5000974.
10
Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.玻璃体内曲安奈德与玻璃体内联合贝伐单抗和地塞米松治疗弥漫性糖尿病黄斑水肿。
Clin Exp Ophthalmol. 2011 Sep-Oct;39(7):673-81. doi: 10.1111/j.1442-9071.2011.02504.x. Epub 2011 Mar 24.

本文引用的文献

1
Evaluation of the Effect of Intravitreal Bevacizumab (Avastin) in Patients with Diabetic Macular Edema.评价玻璃体内注射贝伐单抗(阿瓦斯汀)治疗糖尿病性黄斑水肿的疗效。
Nepal J Ophthalmol. 2020 Jul;12(24):236-244. doi: 10.3126/nepjoph.v12i2.28959.
2
Bevacizumab for diabetic macular oedema: one-year treatment outcomes from the Fight Retinal Blindness! Registry.贝伐单抗治疗糖尿病性黄斑水肿:来自 Fight Retinal Blindness! 注册研究的一年治疗结果。
Eye (Lond). 2022 Mar;36(3):594-602. doi: 10.1038/s41433-021-01509-x. Epub 2021 Mar 25.
3
[Budget impact of the incorporation of second-line drug treatment for diabetic macular edema in the Brazilian Unified National Health System from the perspective of the Minas Gerais State Health Department, Brazil].[从巴西米纳斯吉拉斯州卫生部的角度看,巴西统一国家卫生系统中纳入糖尿病性黄斑水肿二线药物治疗的预算影响]
Cad Saude Publica. 2019 Aug 22;35(8):e00145518. doi: 10.1590/0102-311X00145518.
4
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.阿柏西普、贝伐单抗或雷珠单抗治疗糖尿病性黄斑水肿。
N Engl J Med. 2015 Mar 26;372(13):1193-203. doi: 10.1056/NEJMoa1414264. Epub 2015 Feb 18.
5
Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7.早期治疗糖尿病性视网膜病变研究:设计与患者基线特征。ETDRS报告第7号。
Ophthalmology. 1991 May;98(5 Suppl):741-56. doi: 10.1016/s0161-6420(13)38009-9.

The treatment of diabetic macular edema with intravitreal bevacizumab in users of the Brazilian public health system.

作者信息

Ibrahim Larissa Fouad, Soares Aleida Nazareth, Costa Lucas Assis, Domingues Thabata Machado Correia, Souza Alessandra Hubner de

机构信息

Faculdade Ciências Médicas de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.

Instituto de Olhos Ciências Médicas de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.

出版信息

Arq Bras Oftalmol. 2024 Sep 13;87(5):e20240146. doi: 10.5935/0004-2749.2024-0146. eCollection 2024.

DOI:10.5935/0004-2749.2024-0146
PMID:39292057
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11627335/
Abstract
摘要